Month-end is a different beast altogether — the surge in orders, the pressure to close, and the endless scramble to keep everything moving without breaking. And in the middle of that chaos, there’s always one manual task that feels like it was designed to test everyone’s patience. Maybe it’s reconciling last-minute orders, validating inventory batches, dealing with credit rechecks, cleaning mismatched POs, or manually tracking fulfilment status while the clock is ticking.

So let’s talk about it.

What’s the one month-end task you wish your team never had to do manually again — and why?
Share your story, your frustration, and what an ideal automated version would look like. The community has a way of turning pain points into playbooks, and your experience might be exactly what someone else needs to fix their next month-end spike.

Let’s turn month-end chaos into month-end clarity — together.

Every order process has that one repetitive task — the one that slows you down, eats up your time, and adds zero joy to your day. Maybe it’s cleaning messy order data, chasing approvals, verifying credit blocks, matching POs, or endlessly updating trackers. Whatever it is, there’s probably a smarter, faster, more automated way to handle it… and someone in this community might already have the perfect workaround.

So here’s your cue:
If you could automate just one repetitive task in your order workflow today, what would it be — and what pain does it solve?

Share your pick, your reason, and even your dream-state solution. Whether it’s a 10-second hack or a full-blown automation idea, drop it in the thread.

Let’s turn everyday frustrations into shared intelligence — and maybe even your next "why didn’t we do this earlier?" moment.

Every team has that one workflow that feels heavier than it should — the rule that keeps breaking, the approval that never aligns, the buyer setup that looks perfect on paper but collapses under real volume. Instead of wrestling with it alone, bring it here.

This community is full of people who’ve navigated the same messiness: odd buyer instructions, high-pressure month-ends, credit checks that derail timelines, allocations that behave unpredictably, or site configurations that create more friction than flow.

Share what you’re stuck on — even if it feels small or oddly specific. Chances are someone has already found a smarter workaround, a cleaner configuration, or a process tweak that can save you time (and sanity).

The goal is simple: turn daily stumbling blocks into shared learnings and practical improvements.

Drop your workflow challenge below. Let’s untangle it together.

Welcome to the front desk of the JAVIS Community, we're happy you are here.

If you only bookmark one space, make it this one.

This is where you’ll see what’s changing, what’s new, and what you need to know to keep using JAVIS confidently.

Here’s what you’ll find here:

Short, skimmable product and platform announcements.

🧩 Notes on behaviour changes that might affect your workflows.

🧭 Pointers to new resources, categories, and programs in the community.

How to use this space:

If you’re new, read the pinned welcome posts first.

Each time you log in, skim the most recent announcement so you’re operating on the latest truth.

If an update raises a question, reply directly in that thread so others can see the clarification too.

Higher near-term costs, longer-term structural shifts expected.

The new U.S.–EU pharma tariff agreement, which caps tariffs at 15% and shields EU drugs from additional Section 232 duties, is set to raise near-term costs by nearly $19 billion. Insurers are likely to absorb the initial impact before prices rise for consumers. With 60% of U.S. drug imports coming from Europe, analysts warn ongoing legal uncertainty around tariff authority could delay investment and trigger a gradual reconfiguration of global pharmaceutical production.

Read More